Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, Bobbaers H
Department of Internal Medicine, University Hospitals, Leuven, Belgium.
Crit Care Med. 2000 Jun;28(6):1871-6. doi: 10.1097/00003246-200006000-00031.
To study the incidence and prognosis of thrombocytopenia in adult intensive care unit (ICU) patients.
Prospective observational cohort study.
The medical ICU of a university hospital and the combined medical-surgical ICU of a regional hospital.
All patients consecutively admitted during a 5-month period.
Patient surveillance and data collection.
The primary outcome measure was ICU mortality. Data of 329 patients were analyzed. Overall ICU mortality rate was 19.5%. A total of 136 patients (41.3%) had at least one platelet count <150 x 10(9)/L. These patients had higher Multiple Organ Dysfunction Score (MODS), Simplified Acute Physiology Score (SAPS) II, and Acute Physiology and Chronic Health Evaluation (APACHE) II scores at admission, longer ICU stay (8 [4-16] days vs. 5 [2-9] days) (median [interquartile range]), and higher ICU mortality (crude odds ratio [OR], 5.0; 95% confidence interval [CI], 2.7-9.1) and hospital mortality than patients with daily platelet counts >150 x 10(9)/L (p < .0005 for all comparisons). Bleeding incidence rose from 4.1% in nonthrombocytopenic patients to 21.4% in patients with minimal platelet counts between 101 x 10(9)/L and 149 x 10(9)/L (p = .0002) and to 52.6% in patients with minimal platelet counts <100 x 10(9)/L (p < .0001). In all quartiles of admission APACHE II and SAPS II scores, a nadir platelet count <150 x 10(9)/L was related with a substantially poorer vital prognosis. Similarly, a drop in platelet count to < or =50% of admission was associated with higher death rates (OR, 6.0; 95% CI, 3.0-12.0; p < .0001). In a logistic regression analysis with ICU mortality as the dependent variable, the occurrence of thrombocytopenia had more explanatory power than admission variables, including APACHE II, SAPS II, and MODS scores (adjusted OR, 4.2; 95% CI, 1.8-10.2).
Thrombocytopenia is common in ICUs and constitutes a simple and readily available risk marker for mortality, independent of and complementary to established severity of disease indices. Both a low nadir platelet count and a large fall of platelet count predict a poor vital outcome in adult ICU patients.
研究成人重症监护病房(ICU)患者血小板减少症的发生率及预后。
前瞻性观察队列研究。
一所大学医院的内科ICU以及一家地区医院的内科-外科联合ICU。
5个月期间连续收治的所有患者。
患者监测及数据收集。
主要结局指标为ICU死亡率。分析了329例患者的数据。总体ICU死亡率为19.5%。共有136例患者(41.3%)至少有一次血小板计数<150×10⁹/L。这些患者入院时的多器官功能障碍评分(MODS)、简化急性生理学评分(SAPS)II以及急性生理学与慢性健康状况评估(APACHE)II评分更高,ICU住院时间更长(8[4 - 16]天 vs. 5[2 - 9]天)(中位数[四分位间距]),与每日血小板计数>150×10⁹/L的患者相比,ICU死亡率更高(粗比值比[OR],5.0;95%置信区间[CI],2.7 - 9.1),医院死亡率也更高(所有比较p <.0005)。出血发生率从非血小板减少症患者的4.1%升至血小板计数最低在101×10⁹/L至149×10⁹/L之间患者的21.4%(p = 0.0002),以及血小板计数最低<100×10⁹/L患者的52.6%(p <.0001)。在入院APACHE II和SAPS II评分的所有四分位数中,最低血小板计数<150×10⁹/L与显著更差的生命预后相关。同样,血小板计数降至入院时的≤50%与更高的死亡率相关(OR,6.0;95% CI,3.0 - 12.0;p <.0001)。在以ICU死亡率为因变量的逻辑回归分析中,血小板减少症的发生比包括APACHE II、SAPS II和MODS评分在内的入院变量具有更强的解释力(校正OR,4.2;95% CI,1.8 - 10.2)。
血小板减少症在ICU中很常见,是一种简单且易于获得的死亡风险标志物,独立于既定的疾病严重程度指标并与之互补。最低血小板计数低和血小板计数大幅下降均预示成人ICU患者的生命结局不佳。